Inhibikase Therapeutics, Inc. (IKT)
1.76
+0.02
(+1.15%)
USD |
NASDAQ |
Feb 20, 16:00
1.765
0.00 (0.00%)
Pre-Market: 20:00
Inhibikase Therapeutics Price : 1.76 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beta Bionics, Inc. | 13.70 |
| ACADIA Pharmaceuticals, Inc. | 23.99 |
| Agenus, Inc. | 3.06 |
| Alnylam Pharmaceuticals, Inc. | 336.19 |
| Savara, Inc. | 5.53 |
Price Related Metrics
| Price to Book Value | 2.928 |
| Earnings Yield | -32.41% |
| Market Cap | 213.43M |